Integra Lifesciences completes enrollment in DuraSorb monofilament mesh IDE study
Integra LifeSciences [WtwhTicker symbol="IART"](Nasdaq: IART)[/WtwhTicker] announced that it completed enrollment ints U.S. DuraSorb trial.
Source: massdevice.com
Page 5 - Tissue Technologies News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Tissue Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Tissue Technologies Today - Breaking & Trending Today
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating ...
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating ...
Source: pr-inside.com
Integra LifeSciences Announces Complete Enrollment in
Achieves Significant Milestone on Pathway to PMA Approval for Two-Stage Breast Reconstruction...
Source: globenewswire.com
Integra LifeSciences : CEO Magazine Publishes Interview with Jan De Witte
CEO Magazine published an exclusive interview with Integra President and CEO Jan De Witte, where Jan talks about our focus on innovating in healthcare and making a positive impact on... | June 20, 2023
Source: marketscreener.com
Integra LifeSciences (NASDAQ:IART) Issues FY 2023 Earnings Guidance
Thomson Reuters consensus EPS estimate of $3.47. The company issued revenue guidance of $2.1 billion-$2.2 billion, compared to the consensus revenue estimate of $2.15 billion. The company updated its FY2023 earnings and revenue guidance.
Source: readymadeinvest.com